MARKSANS NSE · Healthcare · Pharmaceuticals & Biotechnology
Marksans Pharma Limited
₹336.95 NSE close, 25 Sep 2026
Data as of 10 sources, each card shows its own date MF: Aug 2026 portfolios (monthly), 20 AMCs Shares outstanding and close: NSE, 25 Sep 2026 Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collected Deals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026 SLBM: NSE, 25 Sep 2026 · 30 days collected MTF: NSE, 24 Sep 2026 · 29 days collected Flags: NSE, 25 Sep 2026 FPI: Shareholding pattern as of 30 Jun 2026, filed 20 Jul 2026 Pledge: Shareholding pattern as of 30 Jun 2026 Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF houses FPIs Insider and promoter Bulk and block deals Promoter pledge SLBM borrowing MTF book Delivery Red flags
MF holding, % of equity
2.80% ▼ −0.14 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
8.85%
as of 30 Jun 2026
Fund houses holding
4 no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
0.00%
as of 30 Jun 2026
What changed
4 tracked fund houses held MARKSANS in Aug 2026. None entered or exited.
All tracked schemes together held 1.27 cr shares, 2.80% of equity, worth ₹408 cr at the end of Aug 2026.
Index and arbitrage funds held 0.13% of equity; they are left out of the fund-house counts.
MF houses Aug 2026
4 no change m/m
Top buyer Samco Mutual Fund, +0.01% of equity. Top seller UTI Mutual Fund, −0.08% of equity. Index and arbitrage funds hidden.
Named FPIs at 1% or more as of 30 Jun 2026
8.85%
FPI category I + II, % of total shares · 0 named at 1% or more
No FPI held 1% or more of MARKSANS on 30 Jun 2026.
Insider and promoter 29 Jun 2026 to 26 Sep 2026
4 ■ net 0 sh
disclosed transactions · equity bought 2.28 lakh sh, sold 2.28 lakh sh
Latest: Merrill Jean Saldanha (Directors Immediate Relative), Buy 63,273 Equity, 11 Sep 2026, Gift.
Bulk and block deals 25 Sep 2026
No bulk or block deals in MARKSANS on 25 Sep 2026.
Promoter pledge as of 30 Jun 2026
0.00%
of promoter holding · 0.00% of total shares
Promoters had pledged 0 of their 19.88 cr shares on 30 Jun 2026.
SLBM borrowing 25 Sep 2026
NSE listed no SLBS open position for MARKSANS on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in MARKSANS on 25 Sep 2026.
MTF book 24 Sep 2026
54.58 lakh sh ▲ +1.13 lakh vs 23 Sep 2026
percentile 100 of 29 days collected · ₹150 cr financed
54.58 lakh shares, 1.20% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 100 of 29 days collected.
Delivery 25 Sep 2026
33.2% ▼ −5.8 pp vs 20-day average
20-day average 39.0% · percentile 30 of 30 days collected
33.2% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 39.0%; that day sits at percentile 30 of 30 days collected.
Red flags 25 Sep 2026
No F&O
MARKSANS has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed MARKSANS under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.